Trademark Search in Canada

INOZYME

View On IC.GC.CA

REGISTERED

on 29 Sept 2020

Last Applicant/ Owned by

Inozyme Pharma, Inc.

700 Technology Square, 3rd FloorCambridge, MA 02139

Serial Number

1885194 filed on 27^th Feb 2018

Registration Number

TMA1082326 registered on 29^th Sept 2020

Registration expiry Date

29^th Sept 2030

Correspondent Address

DLA PIPER (CANADA) LLP

BAY ADELAIDE - WEST TOWERSUITE 5100 - 333 BAY STREETTORONTO

ONTARIO

M5H2R2

INOZYME

Trademark usage description

pharmaceutical preparations and substances for use in the diagnosis and treatment of bone diseases; pharmaceutical preparations and substances for use Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for use in the diagnosis and treatment of bone diseases; pharmaceutical preparations and substances for use in the diagnosis and treatment of kidney diseases and disorders; pharmaceutical preparations and substances for the treatment and prevention of abnormal mineralization and calcification disorders; pharmaceutical preparations and substances for use in the diagnosis and treatment of tissue diseases and disorders, namely bone disease (rickets), blood vessel (abnormal mineralization of vessels, Intimal Proliferation), kidney(CKD), Skin calcification; pharmaceutical preparations and substances for use in the diagnosis and treatment of circulatory diseases and disorders, namely ENPP1 Deficiency (GACI type I/ARHR2), ABCC6 Deficiency (GACI type II, PXE), Hypopyrophosphatemia and disease of abnormal mineralization of the heart, heart valves, blood vessels, skin, Kidney (hyperphosphaturia, nephrocalcinosis, tubular defects resulting from abnormal phosphorus handling); pharmaceutical preparations and substances for use in the diagnosis and treatment of inborn errors of metabolism, namely ENPP1 Deficiency, ABCC6 Deficiency, Hypopyrophosphatemia; pharmaceutical preparations and substances for use in the diagnosis and treatment of diseases caused by abnormal intimal proliferation; none of the aforesaid including pharmaceuticals for use in the treatment of Pompe disease.

Classification kind code

Mark Details

Serial Number

1885194

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 23^rd Sept 2020	Registration Pending
Submitted for opposition 130 on 21^st Jul 2020	Note to file
Submitted for opposition 42 on 1^st Apr 2020	Advertised
Submitted for opposition 26 on 11^th Mar 2020	Approved
Submitted for opposition 27 on 11^th Mar 2020	Approval Notice Sent
Submitted for opposition 22 on 2^th Jul 2019	Search Recorded
Submitted for opposition 20 on 2^th Jul 2019	Examiner's First Report
Submitted for opposition 31 on 2^th Mar 2018	Formalized
Submitted for opposition 1 on 28^th Feb 2018	Created
Submitted for opposition 30 on 27^th Feb 2018	Filed